XML 34 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurement of Assets and Liabilities
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Assets and Liabilities Fair Value Measurement of Assets and Liabilities
The following tables present our financial assets and liabilities measured at fair value on a recurring basis as of the dates indicated (in millions):
June 30, 2023
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Assets:   
Cash and cash equivalents$2,268 $2,268 $— $— 
Customer accounts380 380 — — 
Short-term investments:
Restricted cash22 22 — — 
Corporate debt securities1,936 — 1,936 — 
Government and agency securities153 — 153 — 
Equity investments with readily determinable fair values97 97 — — 
Total short-term investments2,208 119 2,089 — 
Equity investment in Adevinta2,656 2,656 — — 
Derivatives352 — 69 283 
Long-term investments:
Restricted cash— — 
Corporate debt securities378 — 378 — 
Government and agency securities562 — 562 — 
Equity investment under the fair value option391 — — 391 
Total long-term investments1,335 940 391 
Total financial assets$9,199 $5,427 $3,098 $674 
Liabilities:
Other liabilities$24 $— $— $24 
Derivatives$30 $— $30 $— 
December 31, 2022
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Assets:   
Cash and cash equivalents$2,154 $2,154 $— $— 
Customer accounts69 69 — — 
Short-term investments:
Restricted cash36 36 — — 
Corporate debt securities2,350 — 2,350 — 
Government and agency securities135 — 135 — 
Equity investments with readily determinable fair values104 104 — — 
Total short-term investments2,625 140 2,485 — 
Equity investment in Adevinta2,692 2,692 — — 
Derivatives336 — 122 214 
Long-term investments:
Restricted cash13 13 — — 
Corporate debt securities646 — 646 — 
Government and agency securities557 — 557 — 
Equity investment under the fair value option431 — — 431 
Total long-term investments1,647 13 1,203 431 
Total financial assets$9,523 $5,068 $3,810 $645 
Liabilities:
Other liabilities$14 $— $— $14 
Derivatives$47 $— $47 $— 

Our financial assets and liabilities are valued using market prices on both active markets (Level 1), less active markets (Level 2) and little or no market activity (Level 3). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily available pricing sources for comparable instruments, identical instruments in less active markets, or models using market observable inputs. Level 3 instrument valuations typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. We did not have any transfers of financial instruments between valuation levels during the six months ended June 30, 2023.

Other financial instruments, including accounts receivable and accounts payable, are carried at cost, which approximates their fair value because of the short-term nature of these instruments.

Fair value measurement of derivative instruments

The majority of our derivative instruments are valued using pricing models that take into account the contract terms as well as multiple inputs where applicable, such as equity prices, interest rate yield curves, option volatility and currency rates. Our warrant, which is accounted for as a derivative instrument, is valued using a Black-Scholes model. Key assumptions used in the valuation include risk-free interest rates, Adyen’s common stock price, equity volatility and common stock outstanding, exercise price, and details specific to the warrant. The value is also probability adjusted for management’s assumptions with respect to vesting of the remaining three tranches which are each subject to meeting processing volume milestone targets. These assumptions and the probability of
meeting processing volume milestone targets may have a significant impact on the value of the warrant. Refer to “Note 7 — Derivative Instruments” for further details on our derivative instruments.

The following table presents a reconciliation of the opening to closing balance of assets measured using significant unobservable inputs (Level 3) as of the dates indicated (in millions):
June 30,
2023
December 31,
2022
Opening balance at beginning of period$214 $444 
Change in fair value69 (230)
Closing balance at end of period$283 $214 

The following table presents quantitative information about Level 3 significant unobservable inputs used in the fair value measurement of the warrant as of June 30, 2023 (in millions, except percentages):
Fair value Valuation technique
Unobservable Input (1)
Range (weighted average)
Warrant$283 Black-Scholes and Monte CarloProbability of vesting
0.0% - 55.0% (48.2%)
Equity volatility
(51%)
(1) Probability of vesting was weighted by the unadjusted value of the tranches. For volatility, the average represents the arithmetic average of the points within the range and is not weighted by the relative fair value or notional amount.

Fair value measurement of equity investments

Certain equity investments are measured at fair value on a recurring basis, including our equity investment in Adevinta, equity investments with readily determinable fair values and equity investments under the fair value option.

Our equity investment in Adevinta is accounted for under the fair value option and classified within Level 1 in the fair value hierarchy as the fair value is measured based on Adevinta’s closing stock price and prevailing foreign exchange rate at each balance sheet date. Our equity investments with readily determinable fair values are also classified within Level 1 in the fair value hierarchy as the valuation can be obtained from real time quotes in active markets.

Our equity investment in Gmarket is accounted for under the fair value option and is subject to a two year right held by Emart from the date of disposal to purchase the remaining interest at or near the closing price of the sale.

The following table presents a reconciliation of the opening to closing balance of the equity investment in Gmarket measured using significant unobservable inputs (Level 3) as of the dates indicated (in millions):
June 30,
2023
December 31, 2022
Opening balance at beginning of period$431 $725 
Change in fair value(40)(294)
Closing balance at end of period$391 $431 
This investment is classified within Level 3 in the fair value hierarchy as valuation of the investment reflects management’s estimate of assumptions that market participants would use in pricing the asset. The following table presents quantitative information about Level 3 significant unobservable inputs used in the fair value measurement of the equity investment in Gmarket as of June 30, 2023 that may have a significant impact on the overall valuation (in millions, except multiples):
Fair value Valuation technique
Unobservable Input (1)
Range
Equity investment in Gmarket$391 Market multiplesRevenue multiple — GPC method
0.8x — 1.6x
Revenue multiple — GMAC method
1.0x — 3.9x
(1) The primary unobservable inputs used in the fair value measurement of our equity investment in Gmarket under the fair value option, when using the Guideline Public Company (GPC) method and the Guideline Merged and Acquired Company (GMAC) method under the market multiple approach, are the respective revenue multiples. Significant increases (decreases) in the revenue multiples in isolation would result in significantly higher (lower) fair value measurement. The market multiples are derived from respective groups of guideline public companies and guideline merged and acquired companies.

Certain other immaterial equity investments under the fair value option aggregating to $40 million and $30 million as of June 30, 2023 and December 31, 2022, respectively, are measured at fair value using the net asset value per share (or its equivalent) practical expedient, and have not been classified in the fair value hierarchy.

Refer to “Note 6 — Investments” for further details about our equity investments.